Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway

5 Feb 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Neonatal Health and Biochemistry
Share to Neuroblastoma Research and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38316994
DOI: 10.1038/s41416-024-02599-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathwayPMID 38316994Read ↗

Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe NeuroblastomaSemantic proximity Read ↗

Neuroblastoma treatment in the post-genomic eraSemantic proximity Read ↗

RET-oncogene-targeting drugs draw notice.Semantic proximity Read ↗

Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastomaSemantic proximity Read ↗

Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastomaSemantic proximity Read ↗

Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcomaSemantic proximity Read ↗

Mitofusin-2 in cancer: Friend or foe?Semantic proximity Read ↗

BIOLOGY AND TREATMENT OF NEUROBLASTOMASemantic proximity Read ↗

Neuroblastoma therapy: what is in the pipeline?Semantic proximity Read ↗

BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10Semantic proximity Read ↗

NAMPT: A critical driver and therapeutic target for cancerSemantic proximity Read ↗

The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.